Because the activity of KCC2 is positively controlled by CKB [65,66] and the expression and activity of CKB are reduced in HD [67,68], the function of KCC2 in HD is likely lower, which may subsequently reduce GABAA-mediated inhibitory function. Here, SLC12A5 is linked to Huntington disease.